Under Horizon Europe the second European Innovation Council (EIC) work programme for 2023 has been released. The EIC aims at identifying and supporting breakthrough technologies and game-changing innovations with the potential to scale up internationally and become market leaders. 70% of the entire budget is ear-marked for SMEs, showing the EIC’s clear focus.

At Catalyze, we have obtained funding from the EIC subprogrammes for a wide range of companies, legal entities and academic groups.

EIC programme 2023

3 subprogrammes form the basis of the EIC programme:

EIC programmes


In continuation of the first work programme, both open topic calls and specific challenge-driven calls are available for EIC Pathfinder, EIC Transition and EIC Accelerator. The challenge-driven approach provides funding to address specific technological and innovation breakthroughs. The challenges focus on EU priorities for transitioning to a green, digital and healthy society, as well as the overall strategic planning for Horizon Europe. Each instrument is divided over Open calls and Challenge-driven calls.

Download our Free EIC 2023 Guide

In our EIC 2023 Programme Guide we have gathered all available information for you. We assembled the information on deadlines, budgets, consortia & more in a single guide. A must read if you’re looking for new funding opportunities for your research, R&D or commercialization project.


EIC Guide 2022

The EIC subprogrammes

Pillar 1

EIC Pathfinder

Funding research projects of consortia with a mix of partners from academia and companies, advancing research to develop the scientific basis to underpin breakthrough technologies.

Pillar 2

EIC Transition

Funding consortia of academia and companies, to validate technologies and develop business plans for specific applications. This is a newly added instrument to the EIC programme. Only grantees of ERC Proof of Concept or EIC Pathfinder or FET are eligible to submit an application to this instrument.

Read more

Pillar 3

EIC Accelerator

Focusing on supporting companies (SMEs, start-ups, spin-outs and in exceptional cases small mid-caps) to bring their innovations to market and scale up.

Read more

Catalyze Figure Ovals Whitish

Case: Achilles Therapeutics

Achilles Therapeutics (UK) is pushing the frontier of personalized adoptive T cell therapies. In the first round of the 2022 EIC Pathfinder program, an Achilles-led consortium was awarded €4 million from the “Emerging technologies in cell & gene therapy” Challenge, to develop a proof-of-concept, first-in-class, smart bioprocessing manufacturing platform.


A must-have if you’re interested in getting your business to the next level